Published in Brain on August 20, 2009
The functional neuroanatomy of dystonia. Neurobiol Dis (2011) 2.08
Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol (2012) 1.82
Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4. Am J Hum Genet (2015) 1.22
Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum. Orphanet J Rare Dis (2013) 1.13
Milestones in ataxia. Mov Disord (2011) 1.11
Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxia. Mov Disord (2012) 1.10
RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics (2010) 1.08
Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing. PLoS Genet (2013) 1.03
Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression. Orphanet J Rare Dis (2013) 1.01
Out of balance: R-loops in human disease. PLoS Genet (2014) 0.97
Consensus paper: management of degenerative cerebellar disorders. Cerebellum (2014) 0.95
SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein. Orphanet J Rare Dis (2013) 0.91
R-loops in proliferating cells but not in the brain: implications for AOA2 and other autosomal recessive ataxias. PLoS One (2014) 0.90
Sen-sing RNA terminators. Mol Cell (2011) 0.87
Exome sequencing of a patient with suspected mitochondrial disease reveals a likely multigenic etiology. BMC Med Genet (2013) 0.87
The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician. J Neurol Neurosurg Psychiatry (2012) 0.86
29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype. Orphanet J Rare Dis (2014) 0.85
Interpretation of genetic testing: variants of unknown significance. Continuum (Minneap Minn) (2011) 0.85
Whole-exome sequencing supports genetic heterogeneity in childhood apraxia of speech. J Neurodev Disord (2013) 0.85
Ataxia in children: early recognition and clinical evaluation. Ital J Pediatr (2017) 0.84
The SETX missense variation spectrum as evaluated in patients with ALS4-like motor neuron diseases. Neurogenetics (2012) 0.83
Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2. Hum Mol Genet (2014) 0.82
Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage. J Clin Neurosci (2014) 0.81
(1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2. Brain Res (2010) 0.80
Recent advances in genetics of chorea. Curr Opin Neurol (2016) 0.79
A new model to study neurodegeneration in ataxia oculomotor apraxia type 2. Hum Mol Genet (2015) 0.79
Senataxin protects the genome: Implications for neurodegeneration and other abnormalities. Rare Dis (2013) 0.78
An atypical form of AOA2 with myoclonus associated with mutations in SETX and AFG3L2. BMC Med Genet (2015) 0.78
Senataxin controls meiotic silencing through ATR activation and chromatin remodeling. Cell Discov (2015) 0.77
Ataxia. Neurol Clin (2015) 0.77
Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease. Mech Ageing Dev (2016) 0.76
More Than Ataxia: Hyperkinetic Movement Disorders in Childhood Autosomal Recessive Ataxia Syndromes. Tremor Other Hyperkinet Mov (N Y) (2016) 0.76
Ataxia with oculomotor apraxia type 2: not always an easy diagnosis. Neurol Sci (2015) 0.75
MRI findings in AOA2: Cerebellar atrophy and abnormal iron detection in dentate nucleus. Neuroimage Clin (2013) 0.75
Pseudodominant AOA2. Cerebellum Ataxias (2015) 0.75
STUB1/CHIP mutations cause Gordon Holmes syndrome as part of a widespread multisystemic neurodegeneration: evidence from four novel mutations. Orphanet J Rare Dis (2017) 0.75
DNA repair abnormalities leading to ataxia: shared neurological phenotypes and risk factors. Neurogenetics (2014) 0.75
Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival. J Neurol Sci (2013) 0.75
From anti-GAD to ataxia with ocular motor apraxia type 2: through the looking glass. J Neurol (2013) 0.75
Identification of novel senataxin mutations in Chinese patients with autosomal recessive cerebellar ataxias by targeted next-generation sequencing. BMC Neurol (2016) 0.75
SETX sumoylation: A link between DNA damage and RNA surveillance disrupted in AOA2. Rare Dis (2014) 0.75
Classic ataxia-telangiectasia in a Sudanese boy: Case report and review of the literature. Sudan J Paediatr (2011) 0.75
High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis. Brain Behav (2017) 0.75
Validation of a clinical practice-based algorithm for the diagnosis of autosomal recessive cerebellar ataxias based on NGS identified cases. J Neurol (2016) 0.75
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (1996) 27.61
Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01
A gene map of the human genome. Science (1996) 14.32
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
A physical map of 30,000 human genes. Science (1998) 12.43
Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science (1996) 11.59
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Urban residential environments and senior citizens' longevity in megacity areas: the importance of walkable green spaces. J Epidemiol Community Health (2002) 7.79
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med (1996) 6.57
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
Alcaligenes eutrophus CH34 is a facultative chemolithotroph with plasmid-bound resistance to heavy metals. J Bacteriol (1985) 5.26
Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet (1990) 5.16
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet (2004) 5.06
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum (1993) 5.05
Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet (2000) 5.05
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet (1999) 4.74
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Action spectra for phytochrome A- and B-specific photoinduction of seed germination in Arabidopsis thaliana. Proc Natl Acad Sci U S A (1996) 4.48
Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet (1997) 4.26
Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet (1999) 3.93
The CIC library: a large insert YAC library for genome mapping in Arabidopsis thaliana. Plant J (1995) 3.79
Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature (1997) 3.66
The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet (2000) 3.35
Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet (1996) 3.26
First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet (2001) 3.15
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet (1999) 3.14
A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. Science (1999) 3.12
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet (1997) 3.11
Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet (2001) 3.10
Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology (2006) 3.07
The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet (2001) 3.01
The S receptor kinase determines self-incompatibility in Brassica stigma. Nature (2000) 2.96
Recessive ataxia with ocular apraxia: review of 22 Portuguese patients. Arch Neurol (2001) 2.89
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet (1997) 2.77
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol (2010) 2.74
Drosophila CtBP: a Hairy-interacting protein required for embryonic segmentation and hairy-mediated transcriptional repression. EMBO J (1998) 2.74
Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. Neuron (1998) 2.73
Direct ligand-receptor complex interaction controls Brassica self-incompatibility. Nature (2001) 2.69
Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron (1996) 2.62
Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57
Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg (2007) 2.53
The pollen determinant of self-incompatibility in Brassica campestris. Proc Natl Acad Sci U S A (2000) 2.50
Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology (2007) 2.47
Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology (2009) 2.46
The effect of tetraethylammonium chloride on potassium permeability in the smooth muscle cell membrane of canine trachea. J Physiol (1981) 2.45
Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature (1989) 2.43
Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet (1994) 2.41
Prefrontal and cingulate unit activity during timing behavior in the monkey. Brain Res (1979) 2.41
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet (1996) 2.40
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet (2000) 2.40
Ampulla cardiomyopathy ('Takotusbo' cardiomyopathy)--reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J (2000) 2.39
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA (1999) 2.36
Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology (2009) 2.33
Epidemiological assessment of the health and nutrition of Ethiopian refugees in emergency camps in Sudan, 1985. Br Med J (Clin Res Ed) (1987) 2.29
Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. J Neurosci (1999) 2.27
Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol (1998) 2.25
Flat neoplastic lesions of the colon and rectum detected by high-resolution video endoscopy and chromoscopy. Gastrointest Endosc (1995) 2.22
Multifocal motor neuropathy with and without conduction block: a single entity? Neurology (2006) 2.18
Attentional demands for static and dynamic equilibrium. Exp Brain Res (1993) 2.17
Frequency of the DYT1 mutation in primary torsion dystonia without family history. Arch Neurol (2000) 2.17
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Mental-physical co-morbidity and its relationship with disability: results from the World Mental Health Surveys. Psychol Med (2008) 2.15
Delay activity of orbital and lateral prefrontal neurons of the monkey varying with different rewards. Cereb Cortex (2000) 2.15
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet A (2003) 2.15
Genomic organization of the S locus: Identification and characterization of genes in SLG/SRK region of S(9) haplotype of Brassica campestris (syn. rapa). Genetics (1999) 2.12
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology (2012) 2.12
Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol (2013) 2.11
Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr (1992) 2.11
Shifts in mortality curves: saving or extending lives? . Lancet (1999) 2.11
The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain (1998) 2.11
Laparoscopic observations of congenital anomalies of the liver. Gastrointest Endosc (1998) 2.10
Friedreich ataxia in Louisiana Acadians: demonstration of a founder effect by analysis of microsatellite-generated extended haplotypes. Am J Hum Genet (1992) 2.10
Statistical analysis of the 5' untranslated region of human mRNA using "Oligo-Capped" cDNA libraries. Genomics (2000) 2.09
High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology (2006) 2.09
An autopsy case of troglitazone-induced fulminant hepatitis. Diabetes Care (1998) 2.08
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res (2002) 2.06
Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial. JAMA (2001) 2.06
Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res (2000) 2.06